Slovak Patient Battles Insurance System After Costly Drug Shrinks 13 Tumors

A Slovak woman's fight for access to life-saving medication has highlighted tensions between patients and health insurers in Slovakia. The woman, who suffers from multiple tumors, saw her condition dramatically improve after receiving an expensive drug that reduced 13 tumors — yet her health insurance company rejected her applications for coverage eleven times before she could access treatment. The case underscores broader concerns in Slovakia about the accessibility of costly innovative treatments within the public health insurance system, where insurers can repeatedly deny reimbursement requests for expensive medications even when patients show clear medical need. Such disputes are common in Slovakia, where the approval process for high-cost drugs can leave seriously ill patients in prolonged uncertainty while their conditions progress.